ACC CardiaCast: Understanding AL and ATTR Cardiac Amyloidosis

ACC CardiaCast

İçerik American College of Cardiology tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan American College of Cardiology veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

3y ago 17:59

MP3•Bölüm sayfası

Arşivlenmiş dizi ("Etkin olmayan yayın" status)

When? This feed was archived on June 01, 2023 04:07 (11M ago). Last successful fetch was on April 27, 2023 16:23 (12M ago)

Why? Etkin olmayan yayın status. Sunucularımız bir süredir geçerli bir podcast beslemesi alamadı

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In this episode, Frederick Ruberg, MD, and Mathew Maurer, MD, discuss key topics in cardiac amyloidosis such as the evolving understanding of the epidemiology of the disease, contemporary approaches to diagnosis with an emphasis on noninvasive means, disease course and management of heart failure and conduction disease, as well as the recently approved therapeutics for the two major types of cardiac amyloidosis: light-chain and transthyretin. (Educational grant support is provided by Janssen Oncology.)

96 bölüm

#Fitness #Cardiology #Science #Medicine #American College Of Cardiology